Feb 26 2026 - Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results...
Feb 17 2026 - Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results...
Jan 9 2026 - Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net...
Dec 4 2025 - Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable...
Receive news and updates on Heron’s latest innovations.